Histogen

Histogen

Biotechnology Research

Redefining Regenerative Medicine

About us

Histogen is a regenerative medicine company developing patented technologies that stimulate the body’s stem cells to regenerate tissues and restore youthful function. The Company’s lead therapeutic product has induced hair growth in multiple clinical trials, addressing a multibillion dollar global market. Additional applications of Histogen’s technology span multiple therapeutic and aesthetic areas including skin care, orthopedics, wound healing, and dermal fillers.

Industry
Biotechnology Research
Company size
11-50 employees
Type
Partnership

Locations

Employees at Histogen

Similar pages

Funding

Histogen 14 total rounds

Last Round

Post IPO equity

US$ 5.0M

See more info on crunchbase